Acetaminophen 250 Mg And Ibuprofen 125 Mg Tablet, Film Coated
NDC Package 25000-080-72
Package Information
Acetaminophen 250 Mg And Ibuprofen 125 Mg (acetaminophen 250 mg and ibuprofen 125 mg tablets) tablets is • do not take more than directedadults and children 12 years and over • take 2 caplets every 8 hours while symptoms persistchildren under 12 years • ask a doctor • do not take more than 6 caplets in 24 hours, unless directed by a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Marksans Pharma Limited, this product is identified by NDC 25000-080 and is authorized under FDA application ANDA216994.
Identification & Billing
- RxCUI: 2387532 - acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet
- RxCUI: 2387532 - APAP 250 MG / ibuprofen 125 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 25000 - Marksans Pharma Limited
- 25000-080 - Acetaminophen 250 Mg And Ibuprofen 125 Mg
- 25000-080-72 - 1 BOTTLE in 1 CARTON / 18 TABLET, FILM COATED in 1 BOTTLE
- 25000-080 - Acetaminophen 250 Mg And Ibuprofen 125 Mg
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (25000-080). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 25000-080-72 identifies a specific commercial package of 1 bottle in 1 carton / 18 tablet, film coated in 1 bottle of Acetaminophen 250 Mg And Ibuprofen 125 Mg, a human over the counter drug labeled by Marksans Pharma Limited. This tablet, film coated is formulated for oral use and contains acetaminophen; ibuprofen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Marksans Pharma Limited on July 11, 2023. The current certification is valid through December 31, 2026.
How is this Marksans Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 25000008072. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.